SCHEMBL4970909

SCHEMBL4970909

CC(C)c1cccc(Br)c1.CC(C)c1cccc(C(=O)O)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 1/20 0.55
RXRB P28702 1/20 0.55
RXRG P48443 1/20 0.55
ALDH1A1 P00352 2/20 0.54
SMN1; SMN2 Q16637 3/20 0.52
NPC1 O15118 1/20 0.52
CASP3 P42574 1/20 0.52
RAB9A P51151 1/20 0.52
SENP8 Q96LD8 1/20 0.52
SENP7 Q9BQF6 1/20 0.52
SENP6 Q9GZR1 1/20 0.52
ANPEP P15144 1/20 0.49
ENPEP Q07075 1/20 0.49
MRGPRX4 Q96LA9 2/20 0.47
KAT6A Q92794 1/20 0.46
MAPT P10636 2/20 0.45
PTGS1 P23219 2/20 0.45
CXCR1 P25024 2/20 0.45
CXCR2 P25025 2/20 0.45
PTGS2 P35354 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL105264 0.89 RXRA (0.66) RXRARXRBRXRGALDH1A1SMN1; SMN2
SCHEMBL30444032 0.89 RXRA (0.66) RXRARXRBRXRGALDH1A1SMN1; SMN2
Hydrochloric Acid SCHEMBL27676992 0.88 RXRA (0.64) RXRARXRBRXRGALDH1A1SMN1; SMN2
SCHEMBL10455036 0.83 RXRA (0.68) RXRARXRBRXRGALDH1A1SMN1; SMN2
SCHEMBL29427056 0.82 ALDH1A1 (0.48) RXRARXRBRXRGALDH1A1SMN1; SMN2
SCHEMBL135394 0.82 ALDH1A1 (0.48) RXRARXRBRXRGALDH1A1SMN1; SMN2
SCHEMBL14843614 0.80 ANPEP (0.56) RXRARXRBRXRGALDH1A1SMN1; SMN2
Ethane SCHEMBL17336854 0.80 PARP1 (0.61) ALDH1A1SMN1; SMN2NPC1RAB9AMRGPRX4
Ammonia Solution, Strong SCHEMBL3178489 0.80 ALDH1A1 (0.46) RXRARXRBRXRGALDH1A1SMN1; SMN2
SCHEMBL29537403 0.80 PARP1 (0.65) ALDH1A1SMN1; SMN2MRGPRX4MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966159-A2 CHEMICAL COMPOUNDS AstraZeneca AB (SE) 2008-09-10 EP disclosed
WO-2007071963-A2 QUINAZOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTI-CANCER AGENTS ASTRAZENECA AB (SE) 2007-06-28 WO disclosed